162 related articles for article (PubMed ID: 10435153)
1. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
[TBL] [Abstract][Full Text] [Related]
2. Immunogold labelling of PCNA and Ki-67 antigen at the ultrastructural level in laryngeal squamous cell carcinoma and its correlation with lymph node metastasis and histological grade.
Grzanka A; Sujkowska R; Janiak A; Adamska M
Acta Histochem; 2000 May; 102(2):139-49. PubMed ID: 10824607
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
4. [Expression of EGFR and PCNA, and DNA content in squamous cell carcinoma of larynx].
Ling L; Zhou MY; Wang HE
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Mar; 14(3):99-101. PubMed ID: 12541404
[TBL] [Abstract][Full Text] [Related]
5. [The meaning of the expression of PCNA and c-erbB-2 in the hyperplasia of laryngeal epithelium].
Yao Q; Lu X; Huang Z; Cao Y; Jiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):263-4. PubMed ID: 12563981
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
Zidar N; Gale N; Cör A; Kambic V
J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
[TBL] [Abstract][Full Text] [Related]
8. Expression of EGF, EGFR and PCNA in laryngeal lesions.
Wen QH; Nishimura T; Miwa T; Nagayama I; Furukawa M
J Laryngol Otol; 1995 Jul; 109(7):630-6. PubMed ID: 7561470
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
10. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
11. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
12. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
13. MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.
Vivatvakin S; Ratchataswan T; Leesutipornchai T; Ruangritchankul K; Keelawat S; Mahattanasakul P; Bongsebandhu-Phubhakdi S
Sci Rep; 2021 Jul; 11(1):14607. PubMed ID: 34272446
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
15. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
Broich G; Lavezzi AM; Biondo B; Pignataro LD
In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical markers of cell proliferation in laryngeal carcinoma].
Urpegui García AM; Morandeira García MJ; Soria Navarro J; Rivas Rodríguez P; Valencia Julve J; Fernández Larripa S; Vallés Varela H
Acta Otorrinolaringol Esp; 2000 May; 51(4):279-87. PubMed ID: 10984949
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions.
Chatrath P; Scott IS; Morris LS; Davies RJ; Rushbrook SM; Bird K; Vowler SL; Grant JW; Saeed IT; Howard D; Laskey RA; Coleman N
Br J Cancer; 2003 Sep; 89(6):1048-54. PubMed ID: 12966424
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen in laryngeal cancer.
Krecicki T; Jeleń M
J Laryngol Otol; 1998 Mar; 112(3):310-3. PubMed ID: 9624390
[TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor overexpression desensitizes laryngeal epithelium to carcinogenic effects associated with epidermal growth factor receptor upregulation.
Kourelis K; Vandoros G; Kourelis T; Goumas P; Sotiropoulou-Bonikou G
J Otolaryngol Head Neck Surg; 2009 Apr; 38(2):233-9. PubMed ID: 19442374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
